Search research articles
Contact Us
Filters
Showing results (191-200 of 429) with videos related to
Page
of 43
Sort By:
The Journal of the Association of Physicians of India
|
April 1, 1986
Clinical trial of ethyl acetate extract of gum gugulu (gugulipid) in primary hyperlipidemia
K Gopal, R K Saran, S Nityanand, et al.
Injury
|
July 15, 2025
Implementation of an automated, real-time mortality prediction tool in trauma patients: Can it do more than just predict mortality?
K Gopal, K Diercks, M Cheng, et al.
Oncotarget
|
May 19, 2015
YBX1/YB-1 induces partial EMT and tumourigenicity through secretion of angiogenic factors into the extracellular microenvironment
Shashi K Gopal, David W Greening, Rommel A Mathias, et al.
Oncotarget
|
February 20, 2016
Podoplanin is a component of extracellular vesicles that reprograms cell-derived exosomal proteins and modulates lymphatic vessel formation
Patricia Carrasco-Ramírez, David W Greening, Germán Andrés, et al.
Experimental Hematology
|
January 25, 2017
Androgen receptor expression in mantle cell lymphoma: Potential novel therapeutic implications
Elahe A Mostaghel, Paul S Martin, Stephen Mongovin, et al.
Biorxiv : the Preprint Server for Biology
|
December 16, 2024
HIV-1 single transcription start site mutants display complementary replication functions that are restored by reversion
K Gc, S Lesko, A Emery, et al.
Indian Journal of Malariology
|
December 1, 1987
Specific IgM and IgG antimalarial antibody responses in paired samples from malaria patients
K Gopal, I K Srivastava, R Sinha, et al.
Journal of Virology
|
March 4, 2025
HIV-1 single-transcription start-site mutants display complementary replication functions that are restored by reversion
K Gc, S Lesko, A Emery, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2017
Phase II study of idelalisib, a selective inhibitor of PI3Kδ, for relapsed/refractory classical Hodgkin lymphoma
A K Gopal, M A Fanale, C H Moskowitz, et al.
Blood
|
May 22, 2012
Brentuximab vedotin enables successful reduced-intensity allogeneic hematopoietic cell transplantation in patients with relapsed or refractory Hodgkin lymphoma
Robert Chen, Joycelynne M Palmer, Sandra H Thomas, et al.
Page
of 43
Search research articles
Search
Showing results (191-200 of 429) with videos related to
Sort By:
Page
of 43
The Journal of the Association of Physicians of India
|
April 1, 1986
Clinical trial of ethyl acetate extract of gum gugulu (gugulipid) in primary hyperlipidemia
K Gopal, R K Saran, S Nityanand, et al.
Injury
|
July 15, 2025
Implementation of an automated, real-time mortality prediction tool in trauma patients: Can it do more than just predict mortality?
K Gopal, K Diercks, M Cheng, et al.
Oncotarget
|
May 19, 2015
YBX1/YB-1 induces partial EMT and tumourigenicity through secretion of angiogenic factors into the extracellular microenvironment
Shashi K Gopal, David W Greening, Rommel A Mathias, et al.
Oncotarget
|
February 20, 2016
Podoplanin is a component of extracellular vesicles that reprograms cell-derived exosomal proteins and modulates lymphatic vessel formation
Patricia Carrasco-Ramírez, David W Greening, Germán Andrés, et al.
Experimental Hematology
|
January 25, 2017
Androgen receptor expression in mantle cell lymphoma: Potential novel therapeutic implications
Elahe A Mostaghel, Paul S Martin, Stephen Mongovin, et al.
Biorxiv : the Preprint Server for Biology
|
December 16, 2024
HIV-1 single transcription start site mutants display complementary replication functions that are restored by reversion
K Gc, S Lesko, A Emery, et al.
Indian Journal of Malariology
|
December 1, 1987
Specific IgM and IgG antimalarial antibody responses in paired samples from malaria patients
K Gopal, I K Srivastava, R Sinha, et al.
Journal of Virology
|
March 4, 2025
HIV-1 single-transcription start-site mutants display complementary replication functions that are restored by reversion
K Gc, S Lesko, A Emery, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2017
Phase II study of idelalisib, a selective inhibitor of PI3Kδ, for relapsed/refractory classical Hodgkin lymphoma
A K Gopal, M A Fanale, C H Moskowitz, et al.
Blood
|
May 22, 2012
Brentuximab vedotin enables successful reduced-intensity allogeneic hematopoietic cell transplantation in patients with relapsed or refractory Hodgkin lymphoma
Robert Chen, Joycelynne M Palmer, Sandra H Thomas, et al.
Page
of 43